Related Experiment Video
Updated: Sep 26, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
p63, a key regulator of Ago2, links to the microRNA-144 cluster
Benfan Wang1, H Helena Wu1, Yasser Abuetabh1
1Department of Laboratory Medicine and Pathology, 370 Heritage Medical Research Center, University of Alberta, Edmonton, AB, T6G 2S2, Canada.
Abstract:
As a key component of the RNA-induced silencing complex (RISC), Argonaute2 (Ago2) exhibits a dual function regulatory role in tumor progression. However, the mechanistic basis of differential regulation remains elusive. p63 is a homolog of the tumor suppressor p53. p63 isoforms play a critical role in tumorigenesis and metastasis. Herein, we show that p63 isoforms physically interact with and stabilize Ago2. Expression of p63 isoforms increases the levels of Ago2 protein, while depletion of p63 isoforms by shRNA decreases Ago2 protein levels. p63 strongly guides Ago2 dual functions in vitro and in vivo. Ectopic expression of the miR-144/451 cluster increases p63 protein levels; TAp63 transactivates the miR-144/451 cluster, forming a positive feedback loop. Notably, miR-144 activates p63 by directly targeting Itch, an E3 ligase of p63. Ectopic expression of miR-144 induces apoptosis in H1299 cells. miR-144 enhances TAp63 tumor suppressor function and inhibits cell invasion. Our findings uncover a novel function of p63 linking the miRNA-144 cluster and the Ago2 pathway. FACTS AND QUESTIONS: Identification of Ago2 as a p63 target. Ago2 exhibits a dual function regulatory role in tumor progression; however, the molecular mechanism of Ago2 regulation remains unknown. p63 strongly guides Ago2 dual functions in vitro and in vivo. Unraveling a novel function of p63 links the miRNA-144 cluster and the Ago2 pathway.
Insights
p63 isoforms stabilize Argonaute2 (Ago2) protein, influencing its role in tumor progression. This study reveals a new link between p63, the miR-144 cluster, and the Ago2 pathway in cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- RNA Biology
Background:
- Argonaute2 (Ago2) is crucial for RNA-induced silencing complex (RISC) and has a dual role in tumor progression.
- The precise regulatory mechanisms governing Ago2's function in cancer remain unclear.
- p63, a p53 homolog, is implicated in tumorigenesis and metastasis.
Purpose of the Study:
- To elucidate the interaction between p63 isoforms and Ago2.
- To understand how p63 influences Ago2's dual function in cancer.
- To uncover the role of the miR-144/451 cluster in this regulatory network.
Main Methods:
- Co-immunoprecipitation assays to confirm physical interaction between p63 and Ago2.
- Western blotting to assess protein levels of Ago2 and p63.
- shRNA-mediated depletion of p63 to evaluate its effect on Ago2 levels.
- Luciferase reporter assays and qRT-PCR to study the miR-144/451 cluster regulation.
- In vitro and in vivo experiments to assess tumor suppressor functions.
Main Results:
- p63 isoforms physically interact with and stabilize Ago2 protein levels.
- Depletion of p63 reduces Ago2 protein, while its expression increases Ago2.
- TAp63 transactivates the miR-144/451 cluster, forming a positive feedback loop.
- miR-144 targets Itch, increasing p63 levels and enhancing its tumor suppressor activity.
- miR-144 promotes apoptosis and inhibits cell invasion, mediated by TAp63.
Conclusions:
- p63 isoforms are key regulators of Ago2 protein stability and function in cancer.
- A novel positive feedback loop involving TAp63 and the miR-144/451 cluster is identified.
- miR-144 acts as a tumor suppressor by stabilizing p63 and enhancing its anti-tumorigenic functions.
- This study reveals a new molecular mechanism linking p63, Ago2, and the miR-144 cluster in cancer progression.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
Negative Regulator Molecules
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

